Derma Sciences (DSCI) Says No PK Parameters Could Be Calculated in Latest Study
Tweet Send to a Friend
Derma Sciences, Inc. (Nasdaq: DSCI) announces that all data from the pharmacokinetic (PK) study with 0.03% DSC127 gel has been ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
